Using AI and big data, Weizmann Institute researchers build MiTEs, or natural killer/T-cell Enhancers, to combat cancers, 5 ...

Researchers from Johns Hopkins University have developed an oral treatment that could soon be used to destroy cancer cells ...

Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor ...

If everyone eligible had a lung cancer screening, 62,000 lives would be saved over five years, a new study shows.

Tumor infiltrating lymphocyte (TIL) therapy uses immune cells harvested directly from a patient’s tumor.

Immunotherapy, which harnesses our body's own immune system to fight cancer, has revolutionized modern oncology. Yet despite ...

New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 Clinical Trials Supported by FDA Fast Track ...

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...

Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.